Figure 3.

Percentage of all participants achieving target blood pressure (BP) (<130/85 mm Hg) by week and treatment group (intent‐to‐treat population). Only the first recorded treatment success for each subject was included. The denominator in the calculation of the percentage of participants was the total number of participants in each treatment group at each visit. *If the maximum dosage regimens did not reduce BP to target level, hydrochlorothiazide (HCTZ) 12.5 mg/d was added at week 8 (so weeks 10 and 12 reflect diuretic add‐on therapy).